
On April 23, 2024, Saudi Arabia, the UAE, Qatar, Kuwait, Oman, and Bahrain signed the Gulf Green Packaging Agreement in Riyadh. Effective November 1, 2026, all sterilization systems—including ethylene oxide sterilizers and hydrogen peroxide plasma devices—imported into the Gulf Cooperation Council (GCC) market must be packaged exclusively with materials certified to EN 13485:2023 Annex A (environmentally compliant, biodegradable or recyclable), and carry a verified carbon footprint label. This regulation directly impacts manufacturers, exporters, and suppliers of medical sterilization equipment and packaging components.
On April 23, 2024, six Gulf Cooperation Council (GCC) member states—Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman, and Bahrain—signed the Gulf Green Packaging Agreement in Riyadh. The agreement mandates that, starting November 1, 2026, all sterilization systems entering GCC markets must use 100% packaging materials certified under EN 13485:2023 Annex A for environmental performance (i.e., biodegradability or recyclability), and include a carbon footprint label. No exceptions or transitional allowances are specified in publicly released information.
Exporters of ethylene oxide sterilizers, hydrogen peroxide plasma devices, and related sterilization equipment face immediate compliance pressure. Their current packaging—often aluminum-plastic laminates or polystyrene (PS) trays—does not meet the new material certification requirement. Non-compliant shipments risk rejection at GCC customs or mandatory repackaging, incurring delays and cost penalties.
Suppliers of packaging films, trays, cushioning, and labeling materials must verify whether their existing product lines hold EN 13485:2023 Annex A certification. Those supplying non-certified polymers (e.g., standard PS, PET/Al composites) may lose GCC-bound orders unless they upgrade formulations or obtain third-party validation aligned with the standard’s environmental criteria.
Contract facilities responsible for final packaging, labeling, and palletizing of sterilization systems must adapt assembly lines to handle certified materials—which may differ in tensile strength, sealing temperature, moisture barrier, or print adhesion. Process validation, staff training, and documentation updates (e.g., packaging specifications, DHRs) will be required ahead of the 2026 deadline.
Freight forwarders and customs brokers handling sterilization system imports into GCC countries must update compliance checklists to include verification of EN 13485:2023 Annex A certification documentation and carbon footprint labeling. Absence of either may trigger shipment holds or re-submission requests from GCC regulatory authorities.
While the agreement was signed, no implementing regulations, approved testing protocols, or recognized certification bodies have been formally published as of the signing date. Enterprises should track announcements from the GCC Standardization Organization (GSO) and national authorities (e.g., SASO, ESMA) for clarifications on scope, conformity assessment routes, and label format requirements.
Analysis来看, not all sterilization system models carry equal export volume or packaging complexity. Companies should audit their GCC-bound product portfolio to identify top-10 SKUs by value/volume, then assess current packaging against EN 13485:2023 Annex A eligibility—starting with primary containment (trays, blisters) before secondary (cartons, shrink wrap).
The November 2026 effective date provides a defined timeline, but current implementation details remain sparse. From industry角度看, this is best understood as a binding regulatory signal—not yet an executable checklist. Firms should avoid premature large-scale material procurement; instead, initiate pilot trials with certified material vendors and validate compatibility with existing sterilization and storage conditions.
EN 13485:2023 is a quality management standard for medical devices; its Annex A addresses environmental aspects—but certification pathways for packaging materials specifically are not yet standardized across GCC jurisdictions. Current more appropriate action is to contact accredited labs (e.g., TÜV SÜD, SGS, BSI) to confirm test methods for biodegradability/recyclability verification, and request documentation templates acceptable to GCC authorities.
This agreement is better interpreted as a coordinated regional policy signal than an immediately enforceable technical rule. Observation来看, it reflects GCC’s broader strategy to align medical device import standards with sustainability goals—similar to EU MDR’s environmental considerations, though more prescriptive on packaging. It does not introduce new clinical or safety requirements for sterilization systems themselves, but shifts compliance responsibility upstream to packaging design and supply chain transparency. From industry角度, the real impact lies less in material substitution alone and more in how it accelerates integration of environmental KPIs (e.g., carbon footprint calculation, recyclability traceability) into medical device quality management systems.
Conclusion
The Gulf Green Packaging Agreement signals a structural shift in GCC market access requirements—not just for sterilization equipment exporters, but for the entire packaging value chain serving medical technology. Its significance lies not in immediate enforcement, but in establishing a fixed, non-extendable deadline for systemic adaptation. Currently, it is more accurate to view this as a binding regulatory milestone requiring phased preparation, rather than a sudden compliance event. Enterprises are advised to treat it as a medium-term quality and sustainability integration initiative—not a short-term certification sprint.
Source Information:
Primary source: Official announcement of the Gulf Green Packaging Agreement signed on April 23, 2024, in Riyadh by the governments of Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain.
Note: Technical implementation guidelines, recognized certification bodies, and enforcement procedures remain pending and require ongoing monitoring.
Recommended News
The VitalSync Intelligence Brief
Receive daily deep-dives into MedTech innovations and regulatory shifts.